SIBN vs. FNA, OFIX, IRMD, KIDS, BVS, SRDX, PLSE, SILK, OSUR, and ATRI Should you be buying SI-BONE stock or one of its competitors? The main competitors of SI-BONE include Paragon 28 (FNA), Orthofix Medical (OFIX), Iradimed (IRMD), OrthoPediatrics (KIDS), Bioventus (BVS), Surmodics (SRDX), Pulse Biosciences (PLSE), Silk Road Medical (SILK), OraSure Technologies (OSUR), and Atrion (ATRI). These companies are all part of the "surgical & medical instruments" industry.
Paragon 28 (NYSE:FNA ) and SI-BONE (NASDAQ:SIBN ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.
In the previous week, SI-BONE had 3 more articles in the media than Paragon 28. MarketBeat recorded 8 mentions for SI-BONE and 5 mentions for Paragon 28. Paragon 28's average media sentiment score of 0.44 beat SI-BONE's score of 0.07 indicating that SI-BONE is being referred to more favorably in the news media.
SI-BONE has lower revenue, but higher earnings than Paragon 28. SI-BONE is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks.
Paragon 28 presently has a consensus target price of $16.75, suggesting a potential upside of 118.67%. SI-BONE has a consensus target price of $27.29, suggesting a potential upside of 82.88%. Given SI-BONE's higher possible upside, analysts clearly believe Paragon 28 is more favorable than SI-BONE.
SI-BONE received 131 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 80.56% of users gave Paragon 28 an outperform vote while only 67.23% of users gave SI-BONE an outperform vote.
63.6% of Paragon 28 shares are owned by institutional investors. Comparatively, 98.1% of SI-BONE shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by insiders. Comparatively, 5.4% of SI-BONE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Paragon 28 has a net margin of -24.45% compared to Paragon 28's net margin of -29.93%. Paragon 28's return on equity of -25.14% beat SI-BONE's return on equity.
Paragon 28 has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500.
Summary SI-BONE beats Paragon 28 on 9 of the 17 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding SIBN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
